Awake Prone Positioning in Adults With COVID-19
JAMA Internal Medicine · 2025
DOI: 10.1001/jamainternmed.2025.0011 ↗Kurz gefasst
Metaanalyse in der Zeitschrift JAMA Internal Medicine, 2025. Verfasst von Jian Luo und 41 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Medicine Unit and Oxford National Institute for Health and Care Research (NIHR) Biomedical Research Centre, NDM Experimental Medicine, Un…. Hauptthemen laut MEDLINE: COVID-19, Patient Positioning, Respiratory Insufficiency. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HSRD VA, NHLBI NIH HHS.
Abstract (Originalsprache)
Importance The impact of awake prone positioning (APP) on clinical outcomes in patients with COVID-19 and acute hypoxemic respiratory failure (AHRF) remains uncertain.
Objective
To assess the association of APP with improved clinical outcomes among patients with COVID-19 and AHRF, and to identify potential effect modifiers. Data Sources PubMed, Embase, the Cochrane Library, and ClinicalTrials.gov were searched through August 1, 2024. Study Selection Randomized clinical trials (RCTs) examining APP in adults with COVID-19 and AHRF that reported intubation rate or mortality were included. Data Extraction and Synthesis Individual participant data (IPD) were extracted according to PRISMA-IPD guidelines. For binary outcomes, logistic regression was used and odds ratio (OR) and 95% CIs were reported, while for continuous outcomes, linear regression was used and mean difference (MD) and 95% CIs were reported. Main Outcomes and Measures The primary outcome was survival without intubation. Secondary outcomes included intubation, mortality, death without intubation, death after intubation, escalation of respiratory support, intensive care unit (ICU) admission, time from enrollment to intubation and death, duration of invasive mechanical ventilation, and hospital and ICU lengths of stay.
Results
A total of 14 RCTs involving 3019 patients were included; 1542 patients in the APP group (mean [SD] age, 59.3 [14.1] years; 1048 male [68.0%]) and 1477 in the control group (mean [SD] age, 59.9 [14.1] years; 979 male [66.3%]). APP improved survival without intubation (OR, 1.42; 95% CI, 1.20-1.68), and it reduced the risk of intubation (OR, 0.70; 95% CI, 0.59-0.84) and hospital mortality (OR, 0.77; 95% CI, 0.63-0.95). APP also extended the time from enrollment to intubation (MD, 0.93 days; 95% CI, 0.43 to 1.42 days). In exploratory subgroup analyses, improved survival without intubation was observed in patients younger than age 68 years, as well as in patients with a body mass index of 26 to 30, early implementation of APP (ie, less than 1 day from hospitalization), a pulse saturation to inhaled oxygen fraction ratio of 155 to 232, respiratory rate of 20 to 26 breaths per minute (bpm), and those receiving advanced respiratory support at enrollment. However, none of the subgroups had significant interaction with APP treatment. APP duration 10 or more hours/d within the first 3 days was associated with increased survival without intubation (OR, 1.85; 95% CI, 1.37-2.49). Conclusions and Relevance This IPD meta-analysis found that in adults with COVID-19 and AHRF, APP was associated with increased survival without intubation and with reduced risks of intubation and mortality, including death after intubation. Prolonged APP duration (10 or more hours/d) was associated with better outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Respiratory Medicine Unit and Oxford National Institute for Health and Care Research (NIHR) Biomedical Research Centre, NDM Experimental Medicine, University of Oxford, Oxford, United Kingdom.
- Department of Emergency Medicine, Hôpital de Verdun, Montréal, Quebec, Canada.
- Methods in Patients-Centered Outcomes and Health Research, INSERM UMR 1246, Nantes, France.
- Service de Médecine Intensive-Réanimation, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
- Department of Pulmonology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
- Anaesthesia and Intensive Care, School of Medicine, University of Galway, Galway, Ireland.
Förderung
- HSRD VA
- NHLBI NIH HHS
Zitieren
APA
Luo, J., Pavlov, I., Tavernier, E., Perez, Y., Kharat, A., McNicholas, B., Roca, O., Vines, D. L., Ibarra-Estrada, M., Alhazzani, W., Lewis, K., Simpson, S. Q., Rampon, G., Liu, L., Sun, Q., Qiu, H., Yang, Y., Lapadula, G., Qian, E. T., …, & Awake Prone Positioning Meta-Analysis Group (2025). Awake Prone Positioning in Adults With COVID-19. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2025.0011
Vancouver
Luo J, Pavlov I, Tavernier E, Perez Y, Kharat A, McNicholas B, et al. Awake Prone Positioning in Adults With COVID-19. JAMA Internal Medicine. 2025. doi:10.1001/jamainternmed.2025.0011
BibTeX
@article{Luo2025,
author = {Luo, Jian and Pavlov, Ivan and Tavernier, Elsa and Perez, Yonatan and Kharat, Aileen and McNicholas, Bairbre and Roca, Oriol and Vines, David L and Ibarra-Estrada, Miguel and Alhazzani, Waleed and Lewis, Kimberley and Simpson, Steven Q and Rampon, Garrett and Liu, Ling and Sun, Qin and Qiu, Haibo and Yang, Yi and Lapadula, Giuseppe and Qian, Edward Tang and Gatto, Cheryl L and Rice, Todd W and Parhar, Ken Kuljit S and Weatherald, Jason and Walkey, Allan J and Bosch, Nicholas A and Nay, Mai-Anh and Boulain, Thierry and Fossat, Guillaume and Harris, Tim R E and Thwaites, C Louise and Phong, Nguyen Thanh and Bonfanti, Paolo and Yarahmadi, Sajad and Hashemian, Seyed Mohammadreza and Jayakumar, Devachandran and Taylor, Stephanie Parks and Johnson, Stacy A and Guerin, Claude and Laffey, John G and Ehrmann, Stephan and Li, Jie and Awake Prone Positioning Meta-Analysis Group, Awake Prone Positioning Meta-Analysis Group},
title = {Awake Prone Positioning in Adults With COVID-19},
journal = {JAMA Internal Medicine},
year = {2025},
doi = {10.1001/jamainternmed.2025.0011}
}
EUVIMED